查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1864098

按類型、應用程式、最終用戶、分銷管道、軟體類型和工作流程類型分類的自動化配藥設備市場—全球預測，2025-2032年

Automated Compounding Devices Market by Type, Application, End User, Distribution Channel, Software Type, Workflow Type - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，自動配藥設備市場規模將達到 58.5 億美元，複合年成長率為 10.86%。

關鍵市場統計數據
基準年 2024 25.6億美元
預計年份：2025年 28.4億美元
預測年份 2032 58.5億美元
複合年成長率 (%) 10.86%

一份針對醫療保健決策者的簡明指南，內容涵蓋自動化配藥設備的作用、營運重點、安全預期和整合注意事項。

在現代無菌配藥流程中，自動化配藥設備扮演著日益重要的角色，精準性、可重複性和安全性在此交會融合，以滿足嚴苛的臨床需求。此技術領域涵蓋多種機械結構和軟體層，旨在減少人為操作的差異，提高劑量準確性，並降低污染風險。這些系統在藥房營運、臨床管治和供應鏈管理的交匯點發揮著戰略性作用，並已廣泛應用於包括急診機構、零售藥房、專科藥房和家庭輸液項目在內的各種場所。

臨床複雜性、人力資源限制、日益嚴格的監管以及軟體主導的整合如何重塑藥房的採購重點和營運模式

由於臨床複雜性日益增加、人員短缺以及對無菌配藥流程監管日益嚴格等因素，自動化配藥領域正在經歷變革。先進的腫瘤治療方法和不斷擴大的生物製藥產品組合要求配藥系統能夠容納日益多樣化的藥物類別，同時保持嚴格的隔離和無菌標準。同時，人手不足以及將訓練有素的藥房人員重新部署到臨床工作的需要，加速了人們對自動化的興趣，以減輕人工配藥的負擔，並最大限度地減少高風險任務中的認知負荷。

2025年關稅調整對醫療設備籌資策略、供應商談判趨勢及生命週期成本考量的影響

2025年美國實施的關稅政策調整和貿易措施對自動化配藥設備的籌資策略、供應商選擇和總體擁有成本產生了實際的影響。某些進口醫療設備和組件關稅的提高促使醫療機構和經銷商重新評估其採購方案，一些機構加快了轉向國內製造的替代品和區域供應商的步伐，以降低關稅風險。由於買家尋求保護其營運免受供應鏈中斷和成本上升的影響，這些變化正在影響有關長期服務合約、備件庫存政策和保固條款的談判。

將設備類型、臨床應用案例、最終用戶環境、通路、軟體模型和工作流程模式與採購邏輯聯繫起來的綜合細分分析

細緻的細分框架揭示了設備選擇和實施優先順序如何因技術類型、臨床應用、使用者環境、分銷管道、軟體架構和工作流程模式而異。依類型將設備分類時，蠕動式、活塞式和容積式結構各有其獨特的優點。蠕動式設計通常適用於封閉系統和污染控制模式。活塞式系統可實現對黏稠或黏度可變的製劑的高精度計量。容積式解決方案通常用於高通量液體處理任務。這些技術差異會根據治療和操作需求轉化為不同的適用性。

美洲、歐洲、中東和非洲以及亞太地區醫療保健市場的區域趨勢和採用促進因素正在影響採購選擇、合規要求和服務模式。

在全球範圍內，區域趨勢對採用模式、監管重點和供應商策略有顯著影響。在美洲，先進的醫院基礎設施、不斷擴大的門診輸液市場以及腫瘤和專科藥房等卓越醫療中心的集中分佈正在塑造市場需求。這種環境有利於那些符合嚴格的當地監管標準並與電子健康記錄和條碼檢驗系統緊密整合的解決方案。此外，大規模綜合醫療網路傾向於尋求能夠提供集中支援和跨多個機構標準化工作流程的供應商夥伴關係。

競爭優勢主要體現在整合解決方案、檢驗的工作流程、區域覆蓋範圍以及滿足臨床和營運需求的創新藍圖等方面。

在自動化藥局領域，競爭日益取決於能否提供端到端的解決方案，這些方案需要結合強大的硬體和可互通的軟體、響應迅速的服務網路以及檢驗的工作流程套件。主要企業透過投資人體工學、危險藥物防護技術以及強大的互通性框架來脫穎而出，這些框架能夠實現與藥房資訊系統和電子健康記錄的安全資料交換。此外，能夠提供全面的檢驗支援、用戶培訓計劃和可預測的維護服務契約，也能增強供應商在先進醫療系統採購商中的信譽。

這是一份實用的採購和實施指南，旨在幫助領導者確保系統檢驗，增強服務連續性，並實現自動化帶來的臨床和營運效益。

產業領導者應採取策略性方法，使採購決策與臨床管治目標、營運實際情況和長期服務韌性保持一致。首先，應成立一個跨職能審查委員會，成員包括藥房領導、感染控制、醫療設備管理和採購部門，以確保設備選擇能夠體現臨床、安全和技術方面的優先事項。該委員會應制定客觀標準，考慮防護能力、互通性、檢驗支援和本地服務可用性。

調查方法結合了針對性強的相關人員訪談、法規和標準審查以及供應商檢驗資料，以確保獲得可靠且具有行動導向的洞見。

本執行摘要的研究綜合分析採用三角測量法構建，結合了對臨床藥學負責人、醫療設備工程師和分銷合作夥伴的訪談、對無菌配製相關監管指南和標準的二次分析，以及對供應商技術文獻和產品檢驗材料的系統性回顧。主要研究旨在探索從大型三級醫院到社區藥局等各種類型機構在實際運作中面臨的挑戰、所需功能和服務期望。

將自動化定位為程序性投資，並整合相關策略需求：這需要管治、互通性和持續的績效管理。

在適當的管治和支援下，自動化分發設備能夠顯著提高準確性、安全性和營運擴充性，使其成為現代無菌製劑策略的重要組成部分。設備架構、軟體功能和最終用戶環境之間的相互作用決定了自動化在多大程度上能夠帶來臨床和營運價值。因此，採購決策應基於整體觀點，綜合考量技術適用性、法規遵循、供應商可維護性和人員準備。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 將人工智慧整合到無菌配製工作流程中，以實現預測性維護和流程最佳化
  • 擴展機器人配藥系統並引入條碼檢驗，可減少人為錯誤並加強病患安全措施。
  • 開發一種整合到藥房自動化系統中的封閉式傳輸裝置，用於危險藥物處理合規性檢查。
  • 實施雲端基礎的軟體平台，用於遠端監控藥房營運和即時數據分析
  • 適用於高風險化療和生物製藥的可客製化分裝模組，具備在線連續重量檢驗
  • 轉向採用模組化、擴充性的配藥單元，專為醫院藥房的照護現場應用而設計
  • 引入一次性產品和單次使用無菌盒，以簡化清潔驗證流程並降低交叉污染的風險
  • 藥房設備製造商與電子病歷供應商合作，實現從處方到生產的無縫工作流程
  • 監管審查力度加大，推動了符合 ISO 5 標準且具有自動環境監測功能的分配外殼的普及。
  • 利用網路化自動化技術滿足個人化醫療需求的去中心化藥局中心正在興起。

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：按類型分類的自動配藥設備市場

  • 蠕動型
  • 活塞驅動型
  • 正位移

第9章 按應用分類的自動點膠設備市場

  • 緩解疼痛
  • 化療
    • 普通腫瘤科
    • 標靶治療
  • 靜脈營養
    • 中央靜脈
    • 周邊靜脈

第10章 以最終用戶分類的自動配藥設備市場

  • 配藥藥房
  • 居家醫療
  • 醫院藥房
    • 大型醫院
    • 小規模醫院
  • 零售藥房

第11章：按通路分類的自動配藥設備市場

  • 直銷
  • 經銷商
    • 全國經銷商
    • 區域經銷商
  • 線上銷售

第12章：以軟體類型分類的自動配藥設備市場

  • 融合的
  • 獨立版

第13章：依工作流程類型分類的自動化配藥設備市場

  • 批次
  • 連續型

第14章 各地區的自動配藥設備市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 依組別分類的自動配藥設備市場

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 各國自動配藥設備市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Baxter International Inc.
    • Fresenius Kabi AG
    • B. Braun Melsungen AG
    • ICU Medical, Inc.
    • Omnicell, Inc.
    • Ivenix, Inc.
    • Qcore Medical, Inc.
    • Telstar SA
    • Swisslog AG
    • Capsa Healthcare, Inc.
Product Code: MRR-BB4648AFF305

The Automated Compounding Devices Market is projected to grow by USD 5.85 billion at a CAGR of 10.86% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.56 billion
Estimated Year [2025] USD 2.84 billion
Forecast Year [2032] USD 5.85 billion
CAGR (%) 10.86%

A concise orientation to automated compounding device roles, operational priorities, safety expectations, and integration considerations for healthcare decision-makers

Automated compounding devices are increasingly central to contemporary sterile preparation workflows, where precision, repeatability, and safety converge to meet stringent clinical demands. The technology landscape spans a range of mechanical architectures and software layers designed to reduce manual variability, improve dosing accuracy, and mitigate contamination risks. These systems occupy a strategic role at the intersection of pharmacy operations, clinical governance, and supply chain management, and they are being deployed across acute care settings, retail and specialty compounding pharmacies, and home infusion programs.

As decision-makers consider investments in automated compounding solutions, they are balancing clinical imperatives against operational realities: device integration with existing information systems, compatibility with clinical workflows, staff training needs, and the evolving regulatory scrutiny on aseptic processing. Stakeholders are also observing growing emphasis on traceability and auditability, driven by the need to document chain-of-custody for high-risk preparations. Consequently, procurement evaluation extends beyond the hardware to include software interoperability, vendor support models, and lifecycle maintenance commitments.

In this context, understanding device typologies, application domains, and end-user requirements is essential for framing deployment strategies. Technology choices influence throughput, error rates, and the ability to scale services to meet changing demand patterns. Therefore, an informed introduction to automated compounding must highlight the practical trade-offs between device capabilities, workflow fit, and clinical governance obligations to enable responsible, high-value adoption across care settings.

How clinical complexity, workforce constraints, regulatory rigor, and software-driven integration are reshaping procurement priorities and operational models in compounding

The landscape for automated compounding is undergoing transformative shifts driven by clinical complexity, workforce pressures, and heightened regulatory focus on aseptic processing. Advanced oncology regimens and the widening portfolio of biologics require compounding systems that can handle increasingly diverse drug classes while maintaining stringent containment and sterility profiles. At the same time, labor shortages and the need to reallocate highly trained pharmacy staff toward clinical tasks have accelerated interest in automation that reduces manual preparation burden and minimizes cognitive load during high-risk activities.

Recent technology maturation has emphasized modularity and software-driven orchestration, enabling tighter integration with pharmacy information systems and electronic health records. These developments support improved dose verification, barcode-enabled verification, and electronic batch records that together strengthen quality assurance pathways. Parallel to these technological trends, regulatory authorities are intensifying their expectations for process validation, environmental monitoring, and traceability, prompting providers to prioritize systems with robust audit trails and validated workflows.

Operationally, there is a notable move toward solutions that facilitate decentralized compounding and hybrid service models, where centralized sterile production coexists with point-of-care preparation in outpatient and home settings. This shift is accompanied by renewed attention to supply chain resilience and service continuity, encouraging buyers to evaluate vendor ecosystems for spare parts, local service presence, and software update strategies. Taken together, these factors are reshaping procurement criteria and influencing which device architectures and vendor partnerships are most likely to deliver sustainable clinical and commercial value over time.

Implications of 2025 tariff adjustments on sourcing strategies, vendor negotiation dynamics, and lifecycle cost considerations for device procurement

Tariff policy changes and trade measures enacted in the United States in 2025 have introduced tangible implications for procurement strategies, vendor selection, and total cost of ownership for automated compounding devices. In response to increased duties on certain imported medical devices and components, healthcare organizations and distributors reassessed sourcing options, with some accelerating moves toward domestically manufactured alternatives or regional suppliers to mitigate tariff exposure. These shifts have influenced negotiations around long-term service agreements, spare parts stocking policies, and warranty conditions as buyers sought to insulate operations from supply chain disruptions and cost escalations.

Manufacturers with diversified production footprints or established assembly facilities within tariff-advantaged jurisdictions were relatively better positioned, enabling them to preserve competitive pricing for core devices. Conversely, suppliers reliant on single-country manufacturing faced pressure to absorb higher landed costs or to pass them on to customers, prompting discussions about value-based contracting and extended service commitments to justify revised pricing. For health systems, procurement teams increasingly emphasized total lifecycle assessments, capturing not only acquisition price but also ongoing serviceability, lead times for consumables, and the availability of validated software updates.

Looking ahead, purchasers are incorporating tariff risk into supplier scorecards and contingency planning, evaluating options such as multi-sourcing, local assembly partners, and inventory buffering for critical consumables. These pragmatic responses aim to maintain operational continuity while preserving the clinical benefits of automation. In doing so, organizations are refining procurement policies to balance near-term cost fluctuations against long-term clinical and compliance priorities.

Comprehensive segmentation analysis linking device typologies, clinical use-cases, end-user settings, distribution pathways, software models, and workflow modalities to procurement logic

A nuanced segmentation framework reveals how device selection and deployment priorities vary across technical typologies, clinical applications, user settings, distribution channels, software architectures, and workflow modalities. When categorizing devices by type, peristaltic, piston driven, and volumetric architectures present distinct advantages: peristaltic designs are often favored for closed-system, contamination-controlled modalities; piston driven systems can deliver high-precision dosing for viscous or variable-viscosity formulations; and volumetric solutions are commonly selected for high-throughput liquid handling tasks. These technical differences translate into differential suitability depending on therapeutic and operational needs.

Application-focused segmentation further refines purchasing logic, especially where oncology creates special requirements for containment and hazardous drug handling. Analgesia preparations emphasize dose personalization and rapid turnaround, whereas chemotherapy compounding necessitates secure containment and strict environmental control; within chemotherapy, general oncology regimens and targeted therapies impose divergent requirements for preparation complexity and dose verification. Parenteral nutrition introduces another layer of complexity, where central venous and peripheral venous formulations demand differing volumetric accuracy and compatibility with multi-component mixing protocols.

End-user context shapes operational priorities as well. Compounding pharmacies often prioritize throughput and regulatory documentation; home healthcare services emphasize portability and simplified user interfaces for community nurses; hospital pharmacies need devices that integrate with large electronic ecosystems and accommodate both large hospital and small hospital workflows, each with varying staffing models and physical spaces. Distribution channel dynamics influence access and support models, with direct sales offering close vendor alignment, distributors-whether national or regional-providing reach and aftersales networks, and online sales facilitating transactional procurement for consumables and peripheral software licenses. Software architecture choices between integrated and standalone systems determine how tightly device controls and batch records can be woven into broader pharmacy information systems. Lastly, workflow typologies such as batch and continuous processing define throughput planning and the degree of human oversight required, shaping the physical layout and staffing models around compounding operations. Altogether, this segmentation perspective helps align technical capability with clinical need and operational reality.

Regional dynamics and adoption drivers that shape procurement choices, compliance expectations, and service models across Americas, EMEA, and Asia-Pacific healthcare markets

Regional dynamics exert a material influence on adoption patterns, regulatory priorities, and vendor strategies across the global landscape. In the Americas, demand is shaped by a combination of advanced hospital infrastructure, a growing outpatient infusion market, and concentrated centers of excellence in oncology and specialty pharmacy. This environment favors solutions that demonstrate compliance with rigorous local regulatory standards and that integrate tightly with electronic health records and barcode verification systems. Moreover, large integrated delivery networks often seek vendor partnerships that provide centralized support and standardized workflows across multiple facilities.

In Europe, the Middle East & Africa, regulatory harmonization across certain jurisdictions coexists with notable variations in procurement practices and reimbursement pressures. Providers tend to prioritize clinical safety and environmental controls, while procurement teams evaluate total cost of ownership and service availability across heterogeneous healthcare delivery systems. Regional distributors and localized service organizations play a pivotal role in bridging multinational vendor offerings with local compliance needs and training requirements.

The Asia-Pacific region is characterized by a mix of advanced urban centers with high adoption potential and emerging markets where incremental automation is gaining traction as healthcare capacity expands. In mature urban healthcare systems, integration with hospital information technology and support for high-throughput oncology centers drive demand for robust automation platforms. Meanwhile, in other regional markets, buyers are focused on scalable solutions that balance upfront affordability with modular upgrade paths, enabling phased adoption as clinical volumes and technical capabilities mature. Across all regions, considerations such as local manufacturing, aftersales support footprint, and the availability of regulatory-compliant consumables materially influence vendor competitiveness and adoption velocity.

Competitive differentiators centered on integrated solutions, validated workflows, regional service strength, and innovation roadmaps that address clinical and operational needs

Competitive positioning in the automated compounding space is increasingly influenced by the ability to deliver end-to-end solutions that combine robust hardware with interoperable software, responsive service networks, and validated workflow packages. Leading firms differentiate through investments in human factors engineering, containment technologies for hazardous drugs, and strong interoperability frameworks that enable secure data exchange with pharmacy information systems and electronic health records. In addition, capability to provide comprehensive validation support, user training programs, and predictable maintenance service contracts strengthens vendor credibility with sophisticated health system buyers.

Partnerships between device manufacturers and software integrators are becoming more commonplace, as stakeholders expect seamless batch record generation, barcode verification, and electronic audit trails. Companies that offer modular systems with configurable options for oncology, analgesia, and parenteral nutrition applications are better positioned to address heterogeneous customer needs. Regional service networks and distributor alliances are critical for ensuring timely spare parts delivery and on-the-ground technical support, particularly in markets with complex regulatory or logistical challenges.

Innovation roadmaps that emphasize cloud-enabled analytics, predictive maintenance, and enhanced user interfaces are emerging as differentiators, but they must be balanced against data security and regulatory compliance requirements. Ultimately, providers that demonstrate a commitment to validated workflows, continuous improvement, and transparent post-sale support tend to earn the trust of pharmacy and clinical leaders tasked with safeguarding sterile preparation quality and operational resilience.

Practical procurement and deployment playbook for leaders to secure validated systems, fortify service continuity, and realize clinical and operational gains from automation

Industry leaders should adopt a strategic approach that aligns procurement decisions with clinical governance objectives, operational realities, and long-term service resilience. First, establish a cross-functional evaluation committee that includes pharmacy leadership, infection control, biomedical engineering, and procurement to ensure that device selection reflects clinical, safety, and technical priorities. This committee should define objective criteria that account for containment capabilities, interoperability, validation support, and local service availability.

Second, prioritize vendors who can demonstrate robust integration with existing enterprise systems and who provide validated workflows for the primary clinical applications of interest. Where tariff risk or supply chain fragility exists, consider contractual protections such as price-stability clauses, local assembly options, or predefined parts consignment arrangements to mitigate operational exposure. Additionally, require clear post-sale service-level agreements with measurable response times and defined spare parts availability, so that uptime expectations are aligned with clinical dependency on compounding outputs.

Third, invest in training and change management to ensure effective adoption. Automation gains are realized only when staff are proficient in device operation, troubleshooting, and in reconciling electronic batch records with clinical documentation. Implement phased rollouts-starting with pilot deployments in controlled settings-before scaling across larger hospital or network environments. Finally, embed continuous improvement processes that capture performance metrics, near-miss events, and user feedback to iteratively refine workflows and vendor partnerships. These actions will help leaders transform technology investments into demonstrable improvements in safety, efficiency, and clinical reliability.

Methodological approach combining targeted stakeholder interviews, regulatory and standards review, and vendor validation materials to ensure robust, practice-oriented insights

The research synthesis underpinning this executive summary was developed through a triangulated methodology combining primary interviews with clinical pharmacy leaders, biomedical engineers, and distribution partners; secondary analysis of regulatory guidance and standards relevant to sterile compounding; and a structured review of vendor technical literature and product validation materials. Primary engagements were designed to explore real-world operational challenges, desired feature sets, and service expectations across a spectrum of facility types, from large tertiary hospitals to community-based compounding pharmacies.

Secondary research focused on regulatory frameworks, standard operating procedures for aseptic processing, and best-practice guidance that informs device validation and environmental monitoring. This contextual analysis provided a lens for assessing how product capabilities align with compliance requirements and clinical safety imperatives. Vendor documentation was examined to understand architectural differences between device types, software interoperability options, and service models, with special attention paid to evidence of validated workflows and traceability features.

Synthesis involved iterative validation, where preliminary findings were reviewed with subject-matter experts to ensure accuracy and relevance. The methodology emphasized transparency and reproducibility, documenting assumptions and evidence chains so that stakeholders can assess the provenance of insights. Collectively, this approach supports robust, practice-oriented conclusions while acknowledging the variability in local practice and regulatory interpretation.

Synthesis of strategic imperatives that frame automation as a programmatic investment requiring governance, interoperability, and continuous performance management

Automated compounding devices are now integral to modern sterile preparation strategies, offering pathways to improved precision, enhanced safety, and operational scalability when deployed with appropriate governance and support. The interplay between device architecture, software capabilities, and end-user context determines the degree to which automation delivers clinical and operational value. Consequently, procurement decisions should be informed by a comprehensive view that integrates technical fit, regulatory compliance, vendor serviceability, and workforce readiness.

The current environment presents both opportunities and complexities: advanced therapies and shifting care delivery models increase the clinical need for reliable compounding solutions, while evolving regulatory expectations and supply chain uncertainties demand vigilant procurement and contract design. Organizations that adopt a disciplined, cross-functional approach to evaluation, prioritize interoperability and validated workflows, and secure resilient service arrangements are better positioned to translate automation investments into measurable improvements in safety and efficiency.

In closing, the imperative is clear: treat automation not as an isolated capital purchase but as a strategic program that requires deliberate planning, stakeholder alignment, and continuous performance management. With this posture, healthcare organizations can harness the technical benefits of automated compounding while sustaining the clinical excellence and patient safety that underpin sterile preparation operations.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of artificial intelligence for predictive maintenance and process optimization within sterile compounding workflows
  • 5.2. Expansion of robotic compounding systems with barcode verification to reduce human error and enhance patient safety measures
  • 5.3. Development of closed-system transfer devices integrated within pharmacy automation for hazardous drug handling compliance
  • 5.4. Adoption of cloud-based software platforms for remote monitoring and real-time data analytics of compounding operations
  • 5.5. Customizable dose preparation modules for high-risk chemotherapy and biologics with inline gravimetric verification
  • 5.6. Shift towards modular and scalable compounding units designed for point-of-care applications in hospital pharmacies
  • 5.7. Implementation of disposables and single-use sterile cassettes to streamline cleaning validation and reduce cross-contamination risks
  • 5.8. Collaboration between compounding device manufacturers and electronic health record vendors for seamless prescription to production workflows
  • 5.9. Growing regulatory scrutiny driving adoption of ISO 5 compliant compounding enclosures with automated environmental monitoring
  • 5.10. Emergence of decentralized compounding hubs leveraging networked automation to meet personalized medicine demand

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Automated Compounding Devices Market, by Type

  • 8.1. Peristaltic
  • 8.2. Piston Driven
  • 8.3. Volumetric

9. Automated Compounding Devices Market, by Application

  • 9.1. Analgesia
  • 9.2. Chemotherapy
    • 9.2.1. General Oncology
    • 9.2.2. Targeted Therapy
  • 9.3. Parenteral Nutrition
    • 9.3.1. Central Venous
    • 9.3.2. Peripheral Venous

10. Automated Compounding Devices Market, by End User

  • 10.1. Compounding Pharmacy
  • 10.2. Home Healthcare
  • 10.3. Hospital Pharmacy
    • 10.3.1. Large Hospital
    • 10.3.2. Small Hospital
  • 10.4. Retail Pharmacy

11. Automated Compounding Devices Market, by Distribution Channel

  • 11.1. Direct Sales
  • 11.2. Distributors
    • 11.2.1. National Distributors
    • 11.2.2. Regional Distributors
  • 11.3. Online Sales

12. Automated Compounding Devices Market, by Software Type

  • 12.1. Integrated
  • 12.2. Standalone

13. Automated Compounding Devices Market, by Workflow Type

  • 13.1. Batch
  • 13.2. Continuous

14. Automated Compounding Devices Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Automated Compounding Devices Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Automated Compounding Devices Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Baxter International Inc.
    • 17.3.2. Fresenius Kabi AG
    • 17.3.3. B. Braun Melsungen AG
    • 17.3.4. ICU Medical, Inc.
    • 17.3.5. Omnicell, Inc.
    • 17.3.6. Ivenix, Inc.
    • 17.3.7. Qcore Medical, Inc.
    • 17.3.8. Telstar S.A.
    • 17.3.9. Swisslog AG
    • 17.3.10. Capsa Healthcare, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. AUTOMATED COMPOUNDING DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. AUTOMATED COMPOUNDING DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. AUTOMATED COMPOUNDING DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PERISTALTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PERISTALTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PERISTALTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PERISTALTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PERISTALTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PERISTALTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PISTON DRIVEN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PISTON DRIVEN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PISTON DRIVEN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PISTON DRIVEN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PISTON DRIVEN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PISTON DRIVEN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY VOLUMETRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY VOLUMETRIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY VOLUMETRIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY VOLUMETRIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY VOLUMETRIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY VOLUMETRIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY ANALGESIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY ANALGESIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY ANALGESIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY ANALGESIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY ANALGESIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY ANALGESIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY GENERAL ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY GENERAL ONCOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY GENERAL ONCOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY GENERAL ONCOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY GENERAL ONCOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY GENERAL ONCOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TARGETED THERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TARGETED THERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TARGETED THERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TARGETED THERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CENTRAL VENOUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CENTRAL VENOUS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CENTRAL VENOUS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CENTRAL VENOUS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CENTRAL VENOUS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CENTRAL VENOUS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PERIPHERAL VENOUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PERIPHERAL VENOUS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PERIPHERAL VENOUS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PERIPHERAL VENOUS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PERIPHERAL VENOUS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PERIPHERAL VENOUS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COMPOUNDING PHARMACY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COMPOUNDING PHARMACY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COMPOUNDING PHARMACY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COMPOUNDING PHARMACY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COMPOUNDING PHARMACY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COMPOUNDING PHARMACY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY LARGE HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY LARGE HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY LARGE HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY LARGE HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY LARGE HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY LARGE HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SMALL HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SMALL HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SMALL HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SMALL HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SMALL HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SMALL HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY ONLINE SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY ONLINE SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY INTEGRATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY INTEGRATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY INTEGRATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY INTEGRATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY INTEGRATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY INTEGRATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY STANDALONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY STANDALONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY STANDALONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY STANDALONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY STANDALONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY STANDALONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY BATCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY BATCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY BATCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY BATCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY BATCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY BATCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CONTINUOUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CONTINUOUS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CONTINUOUS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CONTINUOUS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CONTINUOUS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CONTINUOUS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 178. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 179. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 180. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 181. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 182. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 183. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
  • TABLE 184. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, 2025-2032 (USD MILLION)
  • TABLE 185. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2024 (USD MILLION)
  • TABLE 186. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2025-2032 (USD MILLION)
  • TABLE 187. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 188. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 189. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
  • TABLE 190. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2032 (USD MILLION)
  • TABLE 191. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 192. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 193. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
  • TABLE 194. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2025-2032 (USD MILLION)
  • TABLE 195. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2018-2024 (USD MILLION)
  • TABLE 196. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2025-2032 (USD MILLION)
  • TABLE 197. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2018-2024 (USD MILLION)
  • TABLE 198. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2025-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. NORTH AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. NORTH AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 204. NORTH AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
  • TABLE 206. NORTH AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, 2025-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2024 (USD MILLION)
  • TABLE 208. NORTH AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2025-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 210. NORTH AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
  • TABLE 212. NORTH AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 214. NORTH AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 215. NORTH AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
  • TABLE 216. NORTH AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2025-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. NORTH AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2025-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2018-2024 (USD MILLION)
  • TABLE 220. NORTH AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2025-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. LATIN AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 224. LATIN AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 225. LATIN AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 226. LATIN AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
  • TABLE 228. LATIN AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, 2025-2032 (USD MILLION)
  • TABLE 229. LATIN AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2024 (USD MILLION)
  • TABLE 230. LATIN AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2025-2032 (USD MILLION)
  • TABLE 231. LATIN AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 232. LATIN AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
  • TABLE 234. LATIN AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2032 (USD MILLION)
  • TABLE 235. LATIN AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 236. LATIN AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 237. LATIN AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
  • TABLE 238. LATIN AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2025-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2018-2024 (USD MILLION)
  • TABLE 240. LATIN AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2025-2032 (USD MILLION)
  • TABLE 241. LATIN AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2018-2024 (USD MILLION)
  • TABLE 242. LATIN AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2025-2032 (USD MILLION)
  • TABLE 287. MIDDLE EAST AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 288. MIDDLE EAST AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 289. MIDDLE EAST AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. MIDDLE EAST AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 291. MIDDLE EAST AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 292. MIDDLE EAST AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 293. MIDDLE EAST AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
  • TABLE 294. MIDDLE EAST AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, 2025-2032 (USD MILLION)
  • TABLE 295. MIDDLE EAST AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2024 (USD MILLION)
  • TABLE 296. MIDDLE EAST AUTOMATED COMPOU